In the BioHarmony Drug Report Database

"Preview" Icon

Tavaborole

Kerydin (tavaborole) is a small molecule pharmaceutical. Tavaborole was first approved as Kerydin on 2014-07-07. It is used to treat mycoses and onychomycosis in the USA.

 

Trade Name

 

Kerydin
 

Common Name

 

tavaborole
 

ChEMBL ID

 

CHEMBL443052
 

Indication

 

mycoses, onychomycosis
 

Drug Class

 

Boroles, boron compounds

Image (chem structure or protein)

Tavaborole structure rendering